The government wants to reduce the maximum duration of compensation for patients with a long-term illness that is not exempt.

The article discusses the distinction between two types of long-term illnesses (ALD) in France: "exonerating" and "non-exonerating". The former allows for full reimbursement of medical costs and longer sick leave, while the latter, affecting patients with less costly conditions, offers limited support. Recent government changes have reduced the maximum compensation period for non-exonerating ALD from three years to one, aiming to save 100 million euros by 2027. This move targets long-term sick leave, which, despite being a smaller percentage of total sick leaves, accounts for a significant portion of healthcare costs.